Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
2025 · 2nd Quarter (Apr 1 - June 30)
INFUSION PROVIDERS ALLIANCE
Filed by THE MCMANUS GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- THE MCMANUS GROUP
- Filing UUID
- 75d22800-e0be-4e5f-8476-fa80b6a2c209
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.